Gentiopicroside ameliorates lipopolysaccharide-induced acute kidney injury by inhibiting TLR4/NF-κB signaling in mice model. Journal of Pharmaceutical Negative Results [Internet]. 2022 Oct. 7 [cited 2026 Jun. 17];13(4):135-4. Available from: https://www.pnrjournal.com/index.php/home/article/view/1445